Dual-targeting CAR-NK cells

CAR-NK cells · Beijing Biotech

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Dual-targeting CAR-NK cells, covering 2026-03-18 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma [Phase 1]